Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
crispr
4
×
boston blog main
boston top stories
editas medicine
gene editing
life sciences
national blog main
boston
katrine bosley
national top stories
new york blog main
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan
andrew oxtoby
babies
beam therapeutics
biotech week boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
bristol-myers squibb
broad institute
bwb
cancer
ceo
cindy perettie
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr-cas9
cynthia collins
david liu
What
medicine
4
×
ceo
crispr
editas
editing
gene
katrine
allergan
benefiting
big
bio
blessing
bosley
bosley's
bosley’s
boston
breathing
bridge
bucks
cas
check
clinical
close
colossal
coming
companies
company
create
crime
crispr’s
cusp
depart
departure
diagnostics
exit
experimental
glimcher
groundbreaking
growing
guiding
Language
unset
Current search:
crispr
×
biotech
×
medicine
×
@techcrunch.com
2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
